跳至主要内容
临床试验/ISRCTN24117387
ISRCTN24117387已完成未知

Implementing Multifactorial Psychotherapy Research in Online Virtual Environments 2 (IMPROVE-2)

niversity of Exeter (UK)0 个研究点目标入组 767 人开始时间: 2014年8月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
767

研究概览

简要总结

2016 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/27716200 protocol 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37378962/ (added 29/06/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 or older
  • 2. Access to internet and an email account that will be maintained and regularly checked for at least 3 months (changed from 20 weeks on 22/09/2016)
  • 3. Competent at reading and writing in English
  • 4. Receiving treatment within BEME Cornwall IAPT service. Those living elsewhere in England can take part as long as they are registered with a UK GP (sentence added 27/09/2016)
  • 5. Meeting caseness for depression, as indexed by a score of 10 or more on the Patient Health Questionnaire-9 (PHQ-9) (Kroenke, Spitzer & Williams, 2001)
  • 6. Completion of the introductory module of the therapy
  • 7. Signed consent to participate

排除标准

  • 1. Identification of comorbid severe or enduring mental health problems other than depression such as current alcohol or drug abuse problems, psychosis or bipolar disorder, either during routine screening by the NHS IAPT service, by online mood screener, or via research structured diagnostic interview at initial assessment.
  • 2. Persistent self-injury requiring clinical management/therapy
  • 3. Unable to engage with internet treatment for physical, practical or other reasons (e.g., very disabling physical or mental health problem, unable to comprehend materials, poor reading)
  • 4. Formal concurrent face-to-face psychotherapy/counselling including computer-based CBT; IAPT treatments
  • 5. Elevated levels of suicide risk as indicated by reporting suicidal ideation and intentions/plans for suicide

研究者

发起方
niversity of Exeter (UK)

相似试验

Implementing multifactorial psychotherapy research... | 临床试验